EnteroMedics Inc. Daily Stock Analysis

Daily Stock Analysis, ETRM, EnteroMedics Inc, priceseries

EnteroMedics Inc. Daily Stock Analysis
Stock Information
Open
1.98
Close
2.05
High
2.09
Low
1.96
Previous Close
1.98
Daily Price Gain
0.07
YTD High
30.41
YTD High Date
Jan 10, 2017
YTD Low
1.60
YTD Low Date
Sep 28, 2017
YTD Price Change
0.17
YTD Gain
9.04%
52 Week High
30.41
52 Week High Date
Jan 10, 2017
52 Week Low
0.03
52 Week Low Date
Dec 28, 2016
52 Week Price Change
1.99
52 Week Gain
3266.17%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 14. 2015
21.00
Jan 15. 2015
22.05
1 Trading Days
5.00%
Link
LONG
Oct 28. 2015
3.75
Nov 5. 2015
3.98
6 Trading Days
6.00%
Link
LONG
Dec 30. 2015
2.10
Dec 31. 2015
2.40
1 Trading Days
14.21%
Link
LONG
Jan 4. 2016
1.97
Jan 5. 2016
2.11
1 Trading Days
7.16%
Link
LONG
Jan 3. 2017
1.88
Jan 17. 2017
10.70
9 Trading Days
469.11%
Link
LONG
May 10. 2017
4.42
May 16. 2017
4.84
4 Trading Days
9.50%
Link
LONG
Oct 16. 2017
2.24
Oct 17. 2017
2.42
1 Trading Days
8.04%
Link
Company Information
Stock Symbol
ETRM
Exchange
NasdaqCM
Company URL
http://http://www.enteromedics.com
Company Phone
-
CEO
Dan W. Gladney
Headquarters
Minnesota
Business Address
-
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001371217
About

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.

Description

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading